There has been a lot of controversy over the association between obesity and the eventual biochemical failure of men treated for prostate cancer. Research performed at the Cleveland Clinic, Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio attempted to determined whether there is an association between body mass index and biochemical failure [...]
Since the approval of Provenge in April of 2010 the pipeline of new potential immunotherapy drugs has swelled. For excellent reasons, many of us are very optimistic about the future. […]
Men who experience a reoccurrence post surgery will usually be referred for salvage radiation therapy. The goal of the radiation is to simply eliminate the stray cancer cells that might have remained in the prostate bed. The only way we currently have to monitor the outcomes from this radiation is to monitor PSA. Researchers at [...]
We are about to enter into a dark period in health care which is best exemplified by the roaring debate over the issue about Medicare funding for Provenge. The bottom line of the debate comes down simply to, what is the value of one human life? […]
We all have a man or men in our life whom we love, respect and wish to honor. November 21, which is fast approaching, is a date which is being set aside to honor them. November 21 is our country’s first annual MENS HEALTH NIGHT. On this night we all have an opportunity to honor [...]